StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) stock

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$19.37+0.01 (+0.05%)

Close on Nov 17, 2026Market cap $930.89MP/E –Yield –

Odyssey Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Odyssey Therapeutics's total assets was $483.85M at Jun 30, 2026. For fiscal 2025 it was $269.79M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$269.79M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$483.85M–
Q1 FY2026Mar 31, 2026$229.07M–
Q4 FY2025Dec 31, 2025$269.79M–

More Odyssey Therapeutics figures

See a number that looks wrong?